Literature DB >> 32618895

Circadian variations in blood pressure and their implications for the administration of antihypertensive drugs: is dosing in the evening better than in the morning?

Michel Burnier1, Reinhold Kreutz2, Krzysztof Narkiewicz3, Sverre Kjeldsen4, Suzanne Oparil5, Giuseppe Mancia6.   

Abstract

: Blood pressure (BP) follows a circadian rhythm with a physiological decrease during the night. Studies have demonstrated that nocturnal BP as well as its dipping pattern during night-time have a significant prognostic importance for mortality and the occurrence of cardiovascular events. Therefore, hypertension management guidelines recommend to ascertain that patients treated for hypertension have well controlled BP values around the clock. To improve hypertension control during the night and eventually further reduce cardiovascular events, it has been proposed by some to prescribe at least one antihypertensive medication at bedtime. In this review, we have examined the data which could support the benefits of prescribing BP-lowering drugs at bedtime. Our conclusion is that there is no convincing evidence that the administration of BP-lowering drugs in the evening provides any significant advantage in terms of quality of BP control, prevention of target organ damage or reduction of cardiovascular events. Before changing practice for unproven benefits, it would be wise to wait for the results of the ongoing trials that are addressing this issue.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32618895     DOI: 10.1097/HJH.0000000000002532

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  6 in total

1.  Lowering Nighttime Blood Pressure With Bedtime Dosing of Antihypertensive Medications: Controversies in Hypertension - Con Side of the Argument.

Authors:  Ricky D Turgeon; Andrew D Althouse; Jordana B Cohen; Bogdan Enache; John B Hogenesch; Michael E Johansen; Raj Mehta; Gideon Meyerowitz-Katz; Boback Ziaeian; Swapnil Hiremath
Journal:  Hypertension       Date:  2021-08-11       Impact factor: 9.897

Review 2.  Characteristics and control of the 24-hour ambulatory blood pressure in patients with metabolic syndrome.

Authors:  Jian-Feng Huang; Yan Li; Jinho Shin; Yook-Chin Chia; Apichard Sukonthasarn; Yuda Turana; Chen-Huan Chen; Hao-Min Cheng; Arieska Ann Soenarta; Jam Chin Tay; Tzung-Dau Wang; Kazuomi Kario; Ji-Guang Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-02-25       Impact factor: 3.738

3.  Dosing Time Matters? Nighttime vs. Daytime Administration of Nifedipine Gastrointestinal Therapeutic System (GITS) or Amlodipine on Non-dipper Hypertension: A Randomized Controlled Trial of NARRAS.

Authors:  Jing Liu; Xiaofeng Su; Ying Nie; Zhihuan Zeng; Hongyan Chen
Journal:  Front Cardiovasc Med       Date:  2021-11-29

4.  Bedtime versus morning use of antihypertensives for cardiovascular risk reduction (BedMed): protocol for a prospective, randomised, open-label, blinded end-point pragmatic trial.

Authors:  Scott R Garrison; Michael R Kolber; G Michael Allan; Jeffrey Bakal; Lee Green; Alexander Singer; Darryl R Trueman; Finlay A McAlister; Raj S Padwal; Michael D Hill; Braden Manns; Kimberlyn McGrail; Braden O'Neill; Michelle Greiver; Liesbeth S Froentjes; Donna P Manca; Dee Mangin; Sabrina T Wong; Cathy MacLean; Jessica Em Kirkwood; Rita McCracken; James P McCormack; Colleen Norris; Tina Korownyk
Journal:  BMJ Open       Date:  2022-02-24       Impact factor: 2.692

Review 5.  Hypertension Management in Patients with Chronic Kidney Disease.

Authors:  Sean A Hebert; Hassan N Ibrahim
Journal:  Methodist Debakey Cardiovasc J       Date:  2022-09-06

6.  Missing Verification of Source Data in Hypertension Research: The HYGIA PROJECT in Perspective.

Authors:  Mattias Brunström; Sverre E Kjeldsen; Reinhold Kreutz; Knut Gjesdal; Krzysztof Narkiewicz; Michel Burnier; Suzanne Oparil; Giuseppe Mancia
Journal:  Hypertension       Date:  2021-07-07       Impact factor: 10.190

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.